Siu Christine
Insider CIK 1743029 · EIDX See Remarks · GLUE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2026-06-11 | 2026-06-12 | 25,800 | — | $0 | 25,800 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2025-06-13 | 2025-06-16 | 30,700 | — | $0 | 30,700 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-06-12 | 2024-06-13 | 22,100 | — | $0 | 22,100 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2023-06-14 | 2023-06-15 | 20,500 | — | $0 | 20,500 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2022-06-15 | 2022-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2021-06-23 | 2021-06-25 | 47,132 | — | $0 | 47,132 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2021-04-12 | 2021-06-25 | 7,081 | — | $0 | 7,081 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2019-12-09 | 2019-12-11 | 10,000 | — | $0 | 152,191 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-12-09 | 2019-12-11 | 901 | $60.05 | $54.1K | 36,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-12-09 | 2019-12-11 | 9,099 | $59.62 | $542.5K | 37,371 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2019-12-09 | 2019-12-11 | 10,000 | $0.59 | $5.9K | 46,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2019-12-04 | 2019-12-05 | 10,000 | — | $0 | 162,191 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-12-04 | 2019-12-05 | 8,800 | $58.60 | $515.7K | 37,670 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2019-12-04 | 2019-12-05 | 10,000 | $0.59 | $5.9K | 46,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-12-04 | 2019-12-05 | 1,200 | $59.39 | $71.3K | 36,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2019-12-03 | 2019-12-05 | 10,000 | — | $0 | 172,191 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-12-03 | 2019-12-05 | 4,000 | $59.65 | $238.6K | 36,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-12-03 | 2019-12-05 | 5,400 | $58.95 | $318.3K | 40,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-12-03 | 2019-12-05 | 600 | $57.82 | $34.7K | 45,870 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2019-12-03 | 2019-12-05 | 10,000 | $0.59 | $5.9K | 46,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-11-22 | 2019-11-22 | 9,399 | $54.71 | $514.2K | 37,071 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2019-11-22 | 2019-11-22 | 10,000 | $0.59 | $5.9K | 46,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-11-22 | 2019-11-22 | 601 | $55.29 | $33.2K | 36,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2019-11-21 | 2019-11-22 | 10,000 | — | $0 | 182,191 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2019-11-21 | 2019-11-22 | 25,000 | — | $0 | 192,191 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-11-21 | 2019-11-22 | 200 | $56.00 | $11.2K | 36,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-11-21 | 2019-11-22 | 24,800 | $55.12 | $1.37M | 36,670 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2019-11-21 | 2019-11-22 | 25,000 | $0.59 | $14.8K | 61,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2019-07-10 | 2019-07-12 | 5,000 | — | $0 | 217,191 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2019-07-10 | 2019-07-12 | 5,000 | $0.59 | $3.0K | 41,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-07-10 | 2019-07-12 | 5,000 | $39.37 | $196.8K | 36,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2019-06-26 | 2019-06-28 | 17,000 | — | $0 | 222,191 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2019-06-26 | 2019-06-28 | 17,000 | $0.59 | $10.0K | 36,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-06-05 | 2019-06-07 | 300 | $31.03 | $9.3K | 19,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-06-05 | 2019-06-07 | 13,421 | $30.10 | $404.0K | 19,770 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-06-05 | 2019-06-07 | 3,279 | $29.34 | $96.2K | 33,191 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | A Award | 2019-05-31 | 2019-06-07 | 1,769 | $12.01 | $21.2K | 36,470 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2019-04-24 | 2019-04-26 | 5,000 | — | $0 | 239,191 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-04-24 | 2019-04-26 | 5,000 | $26.11 | $130.6K | 34,701 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2019-04-24 | 2019-04-26 | 5,000 | $0.59 | $3.0K | 39,701 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2019-03-19 | 2019-03-21 | 10,871 | — | $0 | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise deriv | 2019-03-19 | 2019-03-21 | 34,662 | — | $0 | 244,191 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2019-03-19 | 2019-03-21 | 34,662 | $0.59 | $20.5K | 46,614 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-03-19 | 2019-03-21 | 11,913 | $19.66 | $234.2K | 34,701 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | M Exercise | 2019-03-19 | 2019-03-21 | 10,871 | $0.15 | $1.6K | 11,952 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | A Award | 2018-11-30 | 2019-03-21 | 1,081 | $12.01 | $13.0K | 1,081 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | A Award deriv | 2018-11-05 | 2018-11-07 | 55,000 | — | $0 | 55,000 | SEC↗ |